MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients

Stralen, Ev;Leguit, R. J.;Begthel, H.;Michaux, Lucienne;Bast, B. J. E. G.;et.al.
(2009) Leukemia — Vol. 23, n° 4, p. 801-803 (2009)

Files

35654.pdf
  • Restricted Access
  • Adobe PDF
  • 156.57 KB

Details

Authors
  • Stralen, Ev
    Author
  • Leguit, R. J.
    Author
  • Begthel, H.
    Author
  • Michaux, Lucienne
    Author
  • Lemmens, HeidiUCLouvain
    Author
  • Doyen, ChantalUCLouvain
    Author
  • Pierre, PatrickUCLouvain
    Author
  • Bast, B. J. E. G.
    Author
Show more
Affiliations

Citations

Stralen, E., Leguit, R. J., Begthel, H., Michaux, L., Buijs, A., Lemmens, H., Scheiff, J.-M., Doyen, C., Pierre, P., Forget, F., Clevers, H. C., & Bast, B. J. E. G. (2009). MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients. Leukemia, 23(4), 801-803. https://doi.org/10.1038/leu.2008.284 (Original work published 2009)